Krishna Komanduri

Dr. Krishna Komanduri is a Professor at the University of California San Francisco (UCSF) specializing in Hematology/Oncology. His research focuses on hematopoietic stem cell transplantation, CAR-T cell therapy, and immunologic approaches to cancer treatment. He has held leadership roles in NIH-funded grants investigating immune reconstitution, graft-versus-host disease, and relapse risk reduction.

• Education: MD from University of Minnesota Medical School, Hematology/Oncology Fellowship at UCSF, Internal Medicine Residency at UCLA, Postdoctoral Fellowship in Immunology at Gladstone Institute

His research interests include:

• Adoptive cell therapy optimization
• Cytokine release syndrome prediction
• Viral infection management post-transplant
• Psychosocial factors in transplant outcomes
• Immune effector cell toxicity
• Stem cell mobilization techniques

His recent publications highlight advancements in CAR-T therapy safety, tumor-infiltrating lymphocyte applications, MMR vaccination protocols post-transplant, and biologic modeling for transplant complications. These works span journals like Blood Advances, JCI Insight, and Transplant Cell & Therapy.

Scientific awards include:

• Elected to Henry Kunkel Society (2021)
• Honorary Fellow of ASTCT (2021)
• Best Doctors in America (2013-2021)
• Division of Cancer Medicine Leadership in Education Award (2008)

He has served as Principal Investigator on NIH grants R01HL091749 and R01CA109326, and Co-Principal Investigator on UG1HL109526. Dr. Komanduri collaborates with multidisciplinary teams across institutions including MD Anderson Cancer Center, UCLA, and global research networks.